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SUMMARY Farber’s disease (FD) is a rare genetic disorder caused by ceramidase defi-
ciency, which results in ceramide accumulation in lung, liver, colon, skeletal muscle, carti-
lage, and bone. Although this disease has been symptomatically characterized, little is
known about its molecular pathogenetic process. Because recent studies reported that cer-
amide accumulation induces GD3 ganglioside formation and apoptosis, we investigated, in
tissue obtained via colonoscopy from seriously involved patients, the possible involvement
of ceramide in FD colonocyte destruction. Histochemical and TUNEL analyses of paraffin-
embedded sections revealed that 45 
 
 4.3% of FD colonocytes showed morphological signs
of apoptosis compared with the 8 
 
 2.3% of constitutive epithelial cell death. Importantly,
immunohistochemical study for pro-apoptotic factors showed that GD3 accumulation co-
localized with active caspase-3 and cleaved K18 in FD colon tissue. These findings provide
evidence for a role of the apoptotic ceramide pathway in the pathogenesis of FD.
(J Histochem Cytochem 48:57–62, 2000)
Farber disease (FD) is a rare lysosomal storage dis-
order, also called Farber lipogranulomatosis, charac-
terized by an inherited deficiency of acid ceramidase
activity (Fujiwaki et al. 1992; Koch et al. 1996), which
catalyzes the hydrolysis of ceramide to free fatty acid
and sphingosine (Moser 1997). This autosomal reces-
sive disorder has variable degrees of severity that cor-
relate with the amount of ceramide accumulation in the
locomotor system and viscera (Qualman et al. 1987).
Although joint pain is the most common symptom,
more severely involved patients may have respiratory,
gastrointestinal, and neurological impairments (Qual-
man et al. 1987; Levade et al. 1995; Moser 1997).
Symptomatology is strictly related to histopathologi-
cal alterations arising early in life. Granulomatous
nodular neoformations appear at muscular and osteo-
cartilagineous levels and cause joint deformities (Moser
1997; Qualman et al. 1987).
Ceramide accumulation results from impaired cera-
mide hydrolysis due to loss of function mutations of
the acid ceramidase gene (Koch et al. 1996). This
leads to cellular alterations characterized by lysosomal
inclusions containing lamellar and curvilinear membrane
(Farber bodies) (Chen and Decker 1982; Abenoza and
Sibley 1987). This process is followed by granuloma-
tous reaction associated with the presence of infiltrat-
ing macrophages, lymphocytes, and fibroblasts (Tanaka
et al. 1979; Burck et al. 1985; Van Echten Deckert et
al. 1997).
Ceramide is a cell signaling molecule involved in a
variety of biological effects in different cell types, in-
cluding cell proliferation and differentiation, inflam-
mation, and apoptosis (Testi 1996; Green and Reed
1998). Recently, it has been shown that, during the
apoptotic process, ceramide is recruited to the gangli-
oside pathway and converted into GD3 ganglioside by
a GD3 synthase (De Maria et al. 1997). Accumulation
of GD3 ganglioside is responsible for the generation of
apoptotic signals in a caspase-dependent or -indepen-
dent manner (De Maria et al. 1997). Moreover, cell-
permeable exogenous ceramide has been demonstrated
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to induce caspase-3 (CPP32/yama/apopain) activation
(Tepper et al. 1997; Anjum et al. 1998; Genestier et
al. 1998).
Caspase-3 is one of the most specific proteases in-
volved in the apoptosis mechanism (Patel et al. 1996).
Caspases are initially produced as inactive precursors,
which are activated after cleavage of inactive pro-
enzymes into heterotetrameric subunits to initiate the
proteolytic cascade (Schwartz 1998; Thornberry and
Lazebnik 1998). Caspase-3 is activated early during
apoptosis, and the activated form is a marker of cells
undergoing apoptosis (Ballou et al. 1996; Schwartz
1998). Furthermore, keratins, in particular K18, a ma-
jor component of intermediate filaments of epithelial
cells, have been shown to be a target of caspases at the
early phases of apoptosis (Caulìn et al. 1997).
In this study we investigated whether ceramide ac-
cumulation in FD triggers the apoptotic machinery in
colon epithelial cells, thus contributing to the patho-
genesis of this genetic disorder.
Materials and Methods
Specimens
Colon mucosal biopsies were obtained at the time of colo-
noscopy. The diagnosis of FD was based on clinical criteria
and was confirmed by acid ceramidase deficiency in cultured
white blood cells (Chatelut et al. 1996). Tissue was obtained
from two patients with FD and from three healthy adults
(age 42 
 
 7.5 years).
Histochemistry
Tissues from each subject were fixed and stained with hema-
toxylin and eosin (H&E) and periodic acid–Schiff (PAS;
Sigma–Aldrich, St Louis, MO) (Spicer 1987).
Immunohistochemistry
Immunohistochemical stains were performed on paraffin-
embedded tissue sections (7 
 
m) obtained from FD colon
and normal human colon specimens. Sections were dewaxed
in xylene and dehydrated through graded alcohols (100% to
30%). Endogenous peroxidase was inhibited by exposing sec-
tions to 3% H2O2 for 10 min at RT. Then sections were rinsed
for 10 min in distilled water. Before starting the immunostain-
ing procedure, sections were treated with citric acid (2 g/liter,
pH 6.0) for 15 min in the microwave for antigen retrieval.
Sections were incubated for 10 min with TBS containing
1% BSA to block aspecific staining. After elimination of ex-
cess serum, sections were exposed for 1 h to specific anti-
bodies anti-Fas (DX2, mouse IgG1; PharMingen, San Diego,
CA), anti-GD3 (S2-566, mouse IgM; Seikagaku, Tokyo, Ja-
pan), anti-CPP32 (clone 19, mouse IgG2a; Transduction Lab-
oratories, Lexington, KY), anti-caspase-3, active form (poly-
clonal rabbit; kindly provided by Merk Frosst, Centre for
Therapeutic Research, Merck Research Laboratories, Kirk-
land, Quebec, Canada), anti-M30 cytodeath (mouse IgG2b;
Boehringer Mannheim, Mannheim, Germany) (Leers et al.
1999) or isotype-matched control at appropriate dilutions.
After two washes in TBS, sections were treated with biotiny-
lated anti-rabbit and anti-mouse immunoglobulins and sub-
sequently washed in TBS and incubated with streptavidin–
peroxidase (Dako LSAB 2 Kit; Dako, Carpinteria, CA). De-
tection was revealed using 3-amino-9-ethylcarbazole (AEC)
as a colorimetric substrate. Counterstaining of tissue sec-
tions was performed using aqueous hematoxylin. Sections
were rinsed in water, mounted in aqueous mounting me-
dium, and analyzed by light microscopy.
In Situ Apoptosis Detection
TdT-mediated dUTP nick end-labeling (TUNEL) reaction
was detected in serial paraffin-embedded sections. After de-
waxing, sections were washed twice with PBS and cells per-
meabilized with 0.1% Triton X-100, 0.1% sodium citrate
for 2 min on ice. Then, in situ apoptosis detection was per-
formed with an In Situ Cell Death Detection AP Kit (Boeh-
ringer Mannheim; Indianapolis, IN). DNA strand break de-
tection was done with an antifluorescein antibody conjugated
with alkaline phosphatase (AP) and revealed by 5-bromo-4-
chloro-3-indolyl-phosphate (BCIP; Dakopatts, Glostrup, Den-
mark). Eosin was used as counterstain. A positive control
was carried out by pretreating the specimens with DNase I
(1
 
g/ml) to introduce nonspecific strand breaks (not shown).
By contrast, the negative control was subjected to the same
staining for TUNEL without terminal deoxynucleotidyl trans-
ferase (TdT) (Stassi et al. 1997a,b,1999). Photography was
performed with a light microscope.
Quantification of Apoptotic Events
H&E-, PAS-, and TUNEL-stained sections were examined
for the scoring of cells undergoing apoptosis, detected mor-
phologically as membrane-bound apoptotic bodies and en-
zymatically as dark blue staining. The number of apoptotic
events was randomly counted in 40 high-power microscopic
fields (
 
40). Approximately 500 nuclei per colon mucosal
biopsy were counted. The number of apoptotic cells was ex-
pressed as number per 100 nuclei. Comparison between the
two groups was performed by Student’s t-test.
Results
Ceramide Accumulation
H&E staining showed normal crypt architecture in
both normal and FD colon tissues, whereas lympho-
cytes, plasma cells, and eosinophils were numerous in
the lamina propria of FD colon mucosa compared to
colon of healthy individuals (Figures 1a and 1b).
In FD tissue, PAS staining showed an abundant ac-
cumulation of polysaccharides, lipids, and glycosphin-
golipids containing ceramide precursors that are rep-
resented by strong purple-red staining (Figure 1d).
Ceramide Accumulation Induces Abundant 
Morphological Changes Associated
with Apoptosis in FD Colonocytes
H&E and PAS scoring analyses showed a large num-
ber of late-stage apoptotic cells in FD colon (Figures
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Figure 1 Colon mucosa from normal
and FD subject stained for (a) H&E, (b)
H&E, (c) PAS, (d) PAS, (e) TUNEL nega-
tive control, (f) TUNEL negative con-
trol, (g) TUNEL, and (h) TUNEL. Ar-
rowheads indicate apoptotic nuclei.
Bars  32 m.
1b and 1d, arrowheads). In situ TUNEL detection re-
vealed massive early- and late-stage DNA fragmenta-
tion stained in dark blue (Figure 1h, arrowheads) com-
pared to a few apoptotic epithelial cells found in normal
colon (Figure 1g). The mitotic activity of stem cells at
the base of the crypts produces a continuous supply of
new cells, which progress to the mucosal surface where
they mature before degeneration by apoptosis.
Most of the normal colon epithelial cells showing
morphological evidence of apoptosis (8 
 
 2.3% of the
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total) were localized to the mucosal surface (Figure 2).
In contrast, whereas only 0.8 
 
 0.2% of crypt cells
were apoptotic in normal colon, a massive number of
colonocytes (45 
 
 4.3%) were apoptotic in crypts
from FD colon (p
 
0.001) (Figures 1g and 1h, ar-
rowheads, and Figure 2). These findings suggest that
ceramide accumulation and triggering of apoptosis
machinery may play an important role in FD cell de-
struction.
Active Caspase-3 Cleaves K18, Leading to Cell Death 
In Vivo
We then investigated whether ceramide-induced apop-
tosis in FD colonocytes showed involvement of cas-
pase activation. Interestingly, analyses of serial colon
sections shows that the active form of caspase-3 in
colonocytes was mostly evident in colon crypt areas
containing abundant reactivity for M30 (Figures 3b–d
and 4c,d), an antibody that specifically recognizes a
caspase cleavage site in K18 that is not detectable in
native K18 of normal cells (Caulìn et al. 1997). In
contrast, normal colon mucosa did not show any im-
munoreactivity evidence for caspase-3 (Figure 3a) or
an active form of caspase-3 or M30 (not shown).
These data suggest that the active form of caspase-3
determines the proteolytic cleavage of K18, leading to
actin cytoskeletal disruption, chromatin condensa-
tion, and packaging of apoptotic bodies in ceramide-
induced apoptosis in FD colonocytes.
GD3 Gangloside Co-localizes with Active Caspase-3 
and Cleaved K18
Accumulation of GD3 ganglioside is an early event in
Fas- and ceramide-induced apoptosis, responsible for
apoptotic signal generation (De Maria et al. 1997). To
determine the relative amount of Fas- and ceramide-
induced pre-apoptosis in FD, we evaluated by immuno-
histochemistry the number of GD3-positive cells. FD
colonocytes express negligible amounts of Fas, as shown
by anti-Fas staining (Figure 3e). In contrast, strong
immunoreactivity for GD3 ganglioside co-localized in
serial sections with FD colonocytes that were positive
for TUNEL, the active form of caspase-3, and M30
(Figures 3d,f and 4a–c), suggesting the rare involve-
ment of the Fas/FasL system and the central role of
GD3 in ceramide-induced apoptosis in FD.
Discussion
Although FD is genetically characterized, the patho-
genic mechanisms determining cell tissue destruction
are still not clear. Ceramide accumulation in FD cells
has been classically regarded as the major pathogenic
factor correlated with the severity of the disease (Qual-
man et al. 1987). This concept was suggested after the
observation that ceramide is accumulated in the lyso-
somal fraction of FD skin fibroblasts showing mem-
branous inclusions and cell destruction (Chen and
Decker 1982). Furthermore, studies have reported
that liver, spleen, and lymph nodes contained massive
histiocytic infiltrates in association with elevated cera-
mide levels (Qualman et al. 1987; Fujiwaki et al.
1992; Zappatini–Tommasi et al. 1992; Moser 1997).
However, although ceramide is believed to play a crit-
ical role in tissue damage, there is no evidence for a
role of ceramide in the death pathway activated in FD.
Apoptosis has been proposed as a key pathogenic
mechanism in several genetic, degenerative, and au-
toimmune diseases (Giordano et al. 1997; Stassi et al.
1997a,b,1999). The data presented here suggest that
the ceramide pathway is responsible for triggering of
apoptosis in FD epithelial cells. A substantial number
of FD colonocytes undergo apoptosis in crypts. In
fact, about 45% of FD colonocytes resident in the
glands are apoptotic and show clear TUNEL reactiv-
ity. However, in normal subjects only a few mucosal
surface colonocytes undergo spontaneous apoptosis,
probably because of the continuous supply of new
cells at the base of crypts. Moreover, we provide evi-
dence that ceramide initiates the apoptotic program
by generating GD3 neosynthesis, resulting in GD3 ac-
cumulation in FD cells.
The interaction of Fas and its ligand is a major apop-
tosis-inducing mechanism. Fas is a surface receptor
expressed on many different cell types (Giordano et al.
1997; Stassi et al. 1997a,b,1999). We and others have
demonstrated that triggering of the Fas molecule re-
sults in a cascade of metabolic events, including acidic
sphingomyelinase activation and ceramide generation,
which is a potent inducer of apoptosis (Cifone et al.
1995; De Maria et al. 1998).
Figure 2 Percentage values of apoptotic cells in normal colon ()
and FD colon (). Bars represent mean values  SD. ***p0.001
for differences between the two groups.
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Fas is rarely expressed in FD colonocytes, sug-
gesting that is not involved in colon epithelial cell ap-
optosis. In contrast, GD3 ganglioside is abundantly
accumulated, probably due to the deficient acid cer-
amidase activity. It is likely that in these cells GD3
acts as an inducer of caspase activation, promoting
cleavage of a number of substrates that eventually re-
sults in cell death.
Recent studies support the idea that caspase-3 acti-
vation is responsible for fragmentation of keratins in
apoptotic epithelial cells by specific cleavage (Caulìn
et al. 1997). Accordingly, we found high levels of ac-
tive form of caspase-3 co-localized with cleaved K18
in FD colonocytes.
In summary, GD3 synthesis induced by a high con-
centration of ceramide may alter mitochondrial func-
tion and promote cell destruction in a caspase-depen-
dent manner, explaining the pathogenic mechanism of
cell injury in FD colonocytes. Apoptosis along the en-
tire colon epithelium down into the crypts may be a
Figure 3 Representative experiment
of normal and FD colon mucosa im-
munostaining. Normal subject: (a)
CPP32. FD patient: (b) CPP32; (c) ac-
tive form of caspase-3; (d) cleaved
keratinin 18 (M30); (e) Fas; (f) GD3.
Bars  32 m.
Figure 4 Co-localization between
TUNEL-positive area and active form
of caspase-3 or cleaved keratin 18 in
FD colonic mucosa. (a) TUNEL; (b) ac-
tive form of caspase-3; (c) M30. Bars 
32 m.
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key pathogenetic factor in the persistent diarrhea and
severe gastrointestinal lesions that occasionally occur
in FD (Fujiwaki et al. 1992; Koga et al. 1992). It is
likely that other epithelia of the digestive system, such
as oropharyngeal and hepatic epithelia, are similarly
affected, thus giving rise to the oropharyngeal lesions
(Haraoka et al. 1997) and obstructive jaundice (No-
waczyk et al. 1996) frequently observed in FD.
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